Answers are grounded in this paper and cite their sources.
Obesity can trigger the onset of a key pathogenetic feature of metabolic syndrome, known as metabolic inflammation (metainflammation). During metainflammation residual macrophages can undergo changes in their polarization state, leading to either increase in arginase or inducible NO-synthase activities, a key enzymes of nitric oxide cycle. Thus, metabolic syndrome development may influence the state of nitric oxide cycle in various organs and tissues. The aim of this study is to evaluate the effect of chromium picolinate on changes of activities of key NO-cycle enzymes (NO-synthases, nitrate and nitrite reductases, arginases) and content of nitric oxide metabolites in rat biceps femoris muscle during metabolic syndrome modelling. Materials and methods. The study was conducted on 24 mature male Wistar rats, weighing between 200 and 260 g. The animals were divided into 4 groups of 6 animals each: I – Control group; II – Metabolic syndrome group. Metabolic syndrome was reproduced by using a 20% fructose solution as the only source of water for 60 days. III – Chromium picolinate administration group. Chromium picolinate was administered daily orally in a dose of 80 µg/kg for 60 days. IV – Administration of chromium picolinate during metabolic syndrome modelling. The object of the study was a 10% homogenate of the biceps femoris muscle of rats. We studied the following biochemical parameters: total, inducible and constitutive NO-synthase activity, arginase activity, nitrite reductase and nitrate reductase activities, concentration of nitrites, peroxynitrites, and nitrosothiols. Results. Administration of chromium picolinate to animals with experimentally induced metabolic syndrome resulted in a 32.30% decrease in total NO-synthase activity compared to the untreated metabolic syndrome group. Activity of inducible NO-synthase decreased by 34.26%. Activity of constitutive NO-synthases increased by 45.16%. Arginase activity was reduced by 41.15%. Nitrate and nitrite reductase activities decreased by 25.57% and 31.45%, respectively. Nitrite concentration increased by 117.97%. Peroxynitrite content in rat biceps femoris muscle decreased by 21.79%. Nitrosothiols content decreased by 34.15%. Conclusions. Administration of chromium picolinate during metabolic syndrome modeling attenuates excessive nitric oxide production in rat biceps femoris muscle by influencing both L-arginine-dependent and L-arginine-independent pathways of its production.
No takes yet. Share an insight, caveat, or question.
Akimov et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: